| Secondary |
| Hypertension |
33.5% |
| Rheumatoid Arthritis |
22.0% |
| Product Used For Unknown Indication |
11.0% |
| Osteoporosis |
4.5% |
| Thrombosis Prophylaxis |
4.5% |
| Gastric Ulcer |
3.0% |
| Peritoneal Dialysis |
3.0% |
| Angina Pectoris |
2.5% |
| Neuroleptic Malignant Syndrome |
2.5% |
| Anxiety |
2.0% |
| Back Pain |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Atrial Fibrillation |
1.0% |
| Cerebral Infarction |
1.0% |
| Constipation |
1.0% |
| Dyslipidaemia |
1.0% |
| Nasopharyngitis |
1.0% |
| Prostate Cancer |
1.0% |
| Schizophrenia |
1.0% |
| Gastritis |
0.5% |
|
| Temporal Lobe Epilepsy |
21.9% |
| Phlebitis |
9.4% |
| Pseudoaldosteronism |
9.4% |
| Haemorrhage Subcutaneous |
6.3% |
| Pyrexia |
6.3% |
| Supraventricular Tachycardia |
6.3% |
| Viral Infection |
6.3% |
| Blood Pressure Decreased |
3.1% |
| Cardiac Failure Congestive |
3.1% |
| Convulsion |
3.1% |
| Dyspnoea |
3.1% |
| Hallucination |
3.1% |
| Heat Illness |
3.1% |
| Hepatic Function Abnormal |
3.1% |
| Neuroleptic Malignant Syndrome |
3.1% |
| Peripheral Nerve Palsy |
3.1% |
| Pulse Absent |
3.1% |
| Sudden Hearing Loss |
3.1% |
|
| Concomitant |
| Hypertension |
32.8% |
| Psoriasis |
11.4% |
| Prophylaxis |
7.0% |
| Gastritis |
5.5% |
| Rheumatoid Arthritis |
4.9% |
| Drug Use For Unknown Indication |
4.3% |
| Angina Pectoris |
3.9% |
| Alcoholic Liver Disease |
3.7% |
| Tinea Infection |
3.7% |
| Diabetes Mellitus |
3.4% |
| Hyperuricaemia |
2.9% |
| Osteoporosis |
2.2% |
| Product Used For Unknown Indication |
2.1% |
| Thrombosis Prophylaxis |
1.9% |
| Antibiotic Prophylaxis |
1.8% |
| Gastric Ulcer |
1.8% |
| Hyperlipidaemia |
1.8% |
| Cerebrovascular Accident Prophylaxis |
1.7% |
| Hepatic Neoplasm Malignant |
1.7% |
| Prostate Cancer |
1.6% |
|
| Pemphigoid |
13.4% |
| Hepatic Function Abnormal |
11.6% |
| White Blood Cell Count Decreased |
10.7% |
| Vomiting |
8.9% |
| Ventricular Tachycardia |
5.4% |
| Interstitial Lung Disease |
4.5% |
| Pneumonia |
4.5% |
| Tooth Extraction |
4.5% |
| Pyrexia |
3.6% |
| Rash |
3.6% |
| Renal Failure |
3.6% |
| Temporal Lobe Epilepsy |
3.6% |
| White Blood Cell Count Increased |
3.6% |
| Angina Pectoris |
2.7% |
| Gait Disturbance |
2.7% |
| Hypoglycaemia |
2.7% |
| Malaise |
2.7% |
| Platelet Count Decreased |
2.7% |
| Renal Disorder |
2.7% |
| Renal Impairment |
2.7% |
|
| Interacting |
| Hypertension |
48.0% |
| Chronic Myeloid Leukaemia |
16.0% |
| Dementia Alzheimer's Type |
12.0% |
| Prophylaxis |
8.0% |
| Drug Use For Unknown Indication |
4.0% |
| Hyperlipidaemia |
4.0% |
| Moyamoya Disease |
4.0% |
| Onychomycosis |
4.0% |
|
| Sick Sinus Syndrome |
42.9% |
| Syncope |
42.9% |
| Sensation Of Heaviness |
14.3% |
|
